Daphne T. Tsoi

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Medicine Access Programmes: what do patients think - a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia.

Medicine Access Programmes: what do patients think - a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia.

Journal: Internal medicine journal

Published: February 16, 2024

A feasibility, safety, and efficacy evaluation of supervised aerobic and resistance exercise for patients with glioblastoma undertaking adjuvant chemoradiotherapy.

A feasibility, safety, and efficacy evaluation of supervised aerobic and resistance exercise for patients with glioblastoma undertaking adjuvant chemoradiotherapy.

Journal: Neuro-oncology practice

Published: May 15, 2023

Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.

Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.

Journal: Clinical breast cancer

Published: July 16, 2022

Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in Australia.

Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in Australia.

Journal: Asia-Pacific journal of clinical oncology

Published: January 26, 2021

Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine.

Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine.

Journal: Trials

Published: August 24, 2018

The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable.

The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable.

Journal: Asia-Pacific journal of clinical oncology

Published: November 17, 2017

Management of patients treated with pertuzumab in the Australian clinical practice setting.

Management of patients treated with pertuzumab in the Australian clinical practice setting.

Journal: Asia-Pacific journal of clinical oncology

Published: June 03, 2016

Exercise Improves Physical Function and Mental Health of Brain Cancer Survivors: Two Exploratory Case Studies.

Exercise Improves Physical Function and Mental Health of Brain Cancer Survivors: Two Exploratory Case Studies.

Journal: Integrative cancer therapies

Published: August 16, 2015

Acute disseminated intravascular coagulation in neuroendocrine carcinoma.

Acute disseminated intravascular coagulation in neuroendocrine carcinoma.

Journal: Case reports in oncology

Published: November 10, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026